Agency Information Collection Activities: Proposed Collection; Comment Request, 7976-7978 [2023-02580]
Download as PDF
ddrumheller on DSK120RN23PROD with NOTICES
7976
Federal Register / Vol. 88, No. 25 / Tuesday, February 7, 2023 / Notices
physician assistants (PAs) to certify the
need for home health services and to
order services in the Medicare and
Medicaid programs. As such, under
CMS–5531–IFC, CMS amended 42 CFR
440.70 to remove the requirement that
the NPPs have to communicate the
clinical finding of the face-to-face
encounter to the ordering physician.
With expanding authority to order home
health services, the CARES Act also
provided that such practitioners are
now capable of independently
performing the face-to-face encounter
for the patient for whom they are the
ordering practitioner, in accordance
with state law. Form Number: CMS–
10609 (OMB control number: 0938–
1319); Frequency: Occasionally;
Affected Public: Private sector (business
or other for-profits); Number of
Respondents: 381,148; Total Annual
Responses: 1,143,443; Total Annual
Hours: 190,955. (For policy questions
regarding this collection contact
Alexandra Eitel at 410–786–0790.)
5. Type of Information Collection
Request: New collection (Request for a
new OMB control number); Title of
Information Collection: Generic
Clearance for CMS and Medicare
Administrative Contractor (MAC)
Generic Customer Experience; Use: The
Centers for Medicare & Medicaid
Services (CMS) is requesting approval to
collect generic feedback from
respondents including, but not limited
to Medicare providers, Medicare
suppliers, provider or supplier staff,
billers, credentialing agencies,
researchers, clearinghouses, consultants,
and attorneys. These surveys will give
us insights into customers’ perceptions
and opinions and will be used to
improve customer experiences and
communications materials; however, the
results will not be generalized to the
population of study.
Improving agency programs requires
ongoing systemic review of service
delivery and program operations
compared to defined standards. We’ll
use multiple methods to collect,
analyze, and interpret information from
this generic clearance to find the
strengths and weaknesses of our current
services. We’ll use this feedback to
inform process improvements or
maintain service quality offered to
providers and stakeholders. Form
Number: CMS–10731 (OMB control
number: 0938–New); Frequency:
Occasionally; Affected Public: Private
sector (business or other for-profits);
Number of Respondents: 997,100; Total
Annual Responses: 997,100; Total
Annual Hours: 50,000. (For policy
questions regarding this collection
VerDate Sep<11>2014
18:52 Feb 06, 2023
Jkt 259001
contact Alyssa Schaub-Rimel at 410–
786–4660.)
Dated: February 2, 2023.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory.
[FR Doc. 2023–02579 Filed 2–6–23; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers CMS–10704, CMS–
10387, CMS–10846, CMS–R–246 and CMS–
10316]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
April 10, 2023.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
SUMMARY:
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs
Division of Regulations Development
Attention: Document Identifier/OMB
Control Number: ll, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, please access the CMS PRA
website by copying and pasting the
following web address into your web
browser: https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–10704 Health Reimbursement
Arrangements and Other AccountBased Group Health Plans
CMS–10387 Minimum Data Set 3.0
Nursing Home and Swing Bed
Prospective Payment System (PPS)
For the collection of data related to
the Patient Driven Payment Model
and the Skilled Nursing Facility
Quality Reporting Program (QRP)
CMS–10846 Medicare Part D
Manufacturer Discount Program
Agreement
CMS–R–246 Medicare Advantage,
Medicare Part D, and Medicare FeeFor-Service Consumer Assessment of
Healthcare Providers and Systems
(CAHPS) Survey
CMS–10316 Implementation of the
Medicare Prescription Drug Plan
(PDP) and Medicare Advantage (MA)
Plan Disenrollment Reasons Survey
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
E:\FR\FM\07FEN1.SGM
07FEN1
Federal Register / Vol. 88, No. 25 / Tuesday, February 7, 2023 / Notices
ddrumheller on DSK120RN23PROD with NOTICES
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Health
Reimbursement Arrangements and
Other Account-Based Group Health
Plans; Use: On June 20, 2019, the
Department of the Treasury, the
Department of Labor, and the
Department of Health and Human
Services (collectively, the Departments)
issued final regulations titled ‘‘Health
Reimbursement Arrangements and
Other Account-Based Group Health
Plans’’ (84 FR 28888) under section
2711 of the PHS Act and the health
nondiscrimination provisions of HIPAA,
Public Law 104–191 (HIPAA
nondiscrimination provisions). The
regulations expanded the use of health
reimbursement arrangements and other
account-based group health plans
(collectively referred to as HRAs) and
recognized certain HRAs as limited
excepted benefits (the excepted benefit
HRA), for plan years beginning on or
after January 1, 2020. In general, the
regulations expanded the use of HRAs
by eliminating the prohibition on
integrating HRAs with individual health
insurance coverage, thereby permitting
employers to offer individual coverage
HRAs to employees that can be
integrated with individual health
insurance coverage or Medicare Parts A
and B, or Part C. Under the regulations,
employees are permitted to use amounts
in an individual coverage HRA to pay
expenses for medical care (including
premiums for individual health
insurance coverage and Medicare),
subject to certain requirements. This
information collection includes
provisions related to substantiation of
individual health insurance coverage
(45 CFR 146.123(c)(5)), the notice
requirement for individual coverage
HRAs (45 CFR 146.123(c)(6)), and
notification of termination of coverage
(45 CFR 146.123(c)(1)(iii)). In the final
rule ‘‘Patient Protection and Affordable
Care Act; HHS Notice of Benefit and
Payment Parameters for 2021; Notice
Requirement for Non-federal
Governmental Plans’’ (85 FR 29164),
under 45 CFR 146.145(b)(3)(viii)(E),
excepted benefit HRAs offered by non-
VerDate Sep<11>2014
18:52 Feb 06, 2023
Jkt 259001
Federal governmental plan sponsors are
required to provide a notice that
describes conditions pertaining to
eligibility to receive benefits, annual or
lifetime caps or other limits on benefits
under the excepted benefit HRA, and a
description or summary of the benefits.
This notice must be provided no later
than 90 days after the employee
becomes a participant in the excepted
benefit HRA and annually thereafter.
Form Number: CMS–10704 (OMB
control number: 0938–1361); Frequency:
Annually; Affected Public: Private
Sector, State Governments; Number of
Respondents: 11,574; Total Annual
Responses: 1,037,674; Total Annual
Hours: 5,889. (For policy questions
regarding this collection contact Adam
Pellillo at (667) 290–9621.)
2. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Minimum Data
Set 3.0 Nursing Home and Swing Bed
Prospective Payment System (PPS) For
the collection of data related to the
Patient Driven Payment Model and the
Skilled Nursing Facility Quality
Reporting Program (QRP); Use: We are
requesting to implement to the MDS 3.0
v1.18.11 beginning October 1, 2023 to
October 1, 2026 in order to meet the
requirements of policies finalized in the
Federal Fiscal Year (FY) 2020 Skilled
Nursing Facility (SNF) Prospective
Payment System (PPS) final rule (84 FR
38728). The compliance date for the
finalized policies (10/01/2020) was
delayed due to the COVID–19 public
health emergency (PHE). While there
has been no change in assessment-level
burden since the approval of the MDS
3.0 v1.17.2, there has been a change in
total burden since 2019 when the
package was originally approved due to
a decrease in the number of MDS
assessments completed and a change in
the hourly rate for clinicians completing
the assessment.
We use the MDS 3.0 PPS Item Set to
collect the data used to reimburse
skilled nursing facilities for SNF-level
care furnished to Medicare beneficiaries
and to collect information for quality
measures and standardized patient
assessment data under the SNF QRP.
There have been some revisions to the
assessment tool since the approval of
MDS 3.0 v1.17.2. Form Number: CMS–
10387 (OMB control number: 0938–
1140); Frequency: Yearly; Affected
Public: Private Sector: Business or other
for-profit and not-for-profit institutions;
Number of Respondents: 15,472; Total
Annual Responses: 3,371,993; Total
Annual Hours: 2,866,194. (For policy
questions regarding this collection
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
7977
contact Heidi Magladry at 410–786–
6034).
3. Type of Information Collection
Request: New Collection (Request for a
new OMB control number); Title of
Information Collection: Medicare Part D
Manufacturer Discount Program
Agreement; Use: Congress enacted the
Inflation Reduction Act of 2022, Public
Law 117–169 (IRA). Section 11201 of
the IRA eliminates the coverage gap
phase of the Part D benefit. It also
sunsets the coverage gap discount
program (CGDP) after December 31,
2024, and amends the Social Security
Act (the Act) to add section 1860D–14C,
requiring the Secretary to establish a
new Medicare Part D manufacturer
discount program (MDP) beginning
January 1, 2025. Under the MDP,
participating manufacturers are required
to provide discounts on their
‘‘applicable drugs’’ (brand drugs,
biologics, and biosimilars) both in the
initial coverage phase and in the
catastrophic coverage phase of the Part
D benefit.
Information in this collection is
needed to set up agreements between
manufacturers and CMS. Under section
1860D–14C(a) of the Act, such
agreements are required for
manufacturers in order to participate in
the MDP and, under section 1860D43(a)
of the Act, for their applicable drugs to
be covered under Part D beginning in
2025. The information collected from
manufacturers in the Health Plan
Management System (HPMS) (Appendix
A) is needed to create and execute MDP
agreements and to determine which
manufacturers qualify as a specified
manufacturer or specified small
manufacturer for phased-in discounts
under section 1860D–14C(g)(4) of the
Act. Banking information collected by
the TPA from manufacturers and plan
sponsors (Appendix B) is needed to
prepare invoices and process financial
transactions (deposits and payments)
through the ACH. Form Number: CMS–
10846 (OMB control number: 0938New); Frequency: Once; Affected Public:
Private Sector: Business or other forprofit and not-for-profit institutions;
Number of Respondents: 659; Total
Annual Responses: 659; Total Annual
Hours: 4,613. (For policy questions
regarding this collection contact Beckie
Peyton at 410–786–1572).
4. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Medicare
Advantage, Medicare Part D, and
Medicare Fee-For-Service Consumer
Assessment of Healthcare Providers and
Systems (CAHPS) Survey; Use: CMS is
required to collect and report
E:\FR\FM\07FEN1.SGM
07FEN1
ddrumheller on DSK120RN23PROD with NOTICES
7978
Federal Register / Vol. 88, No. 25 / Tuesday, February 7, 2023 / Notices
information on the quality of health care
services and prescription drug coverage
available to persons enrolled in a
Medicare health or prescription drug
plan under provisions in the Medicare
Prescription Drug, Improvement, and
Modernization Act of 2003 (MMA).
Specifically, the MMA under Sec.
1860D–4 (Information to Facilitate
Enrollment) requires CMS to conduct
consumer satisfaction surveys regarding
Medicare prescription drug plans and
Medicare Advantage plans and report
this information to Medicare
beneficiaries prior to the Medicare
annual enrollment period. The Medicare
CAHPS survey meets the requirement of
collecting and publicly reporting
consumer satisfaction information. The
Balanced Budget Act of 1997 also
requires the collection of information
about fee-for-service plans.
The primary purpose of the Medicare
CAHPS surveys is to provide
information to Medicare beneficiaries to
help them make more informed choices
among health and prescription drug
plans available to them. Survey results
are reported by CMS in the Medicare &
You Handbook published each fall and
on the Medicare Plan Finder website.
Beneficiaries can compare CAHPS
scores for each health and drug plan as
well as compare MA and FFS scores
when making enrollment decisions. The
Medicare CAHPS also provides data to
help CMS and others monitor the
quality and performance of Medicare
health and prescription drug plans and
identify areas to improve the quality of
care and services provided to enrollees
of these plans. CAHPS data are included
in the Medicare Part C & D Star Ratings
and used to calculate MA Quality Bonus
Payments. Form Number: CMS–R–246
(OMB control number: 0938- 0732);
Frequency: Yearly; Affected Public:
Individuals and Households; Number of
Respondents: 794,500; Total Annual
Responses: 794,500; Total Annual
Hours: 192,265. (For policy questions
regarding this collection contact Lauren
Fuentes at 410–786–2290).
5. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Implementation
of the Medicare Prescription Drug Plan
(PDP) and Medicare Advantage (MA)
Plan Disenrollment Reasons Survey;
Use: The Balanced Budget Act of 1997
required that the CMS publicly report
two years of disenrollment rates on all
Medicare + Choice (M+C) organizations.
Disenrollment rates are a useful measure
of beneficiary dissatisfaction with a
plan; this information is even more
useful when reasons for disenrollment
are provided to consumers, insurers,
VerDate Sep<11>2014
18:52 Feb 06, 2023
Jkt 259001
and other stakeholders. Advocacy
organizations agree that CMS needs to
report disenrollment reasons so that
disenrollment rates can be interpreted
correctly.
Specifically, the MMA under Sec.
1860D–4 (Information to Facilitate
Enrollment) requires CMS to conduct
consumer satisfaction surveys regarding
the PDP and MA contracts pursuant to
section 1860D–4(d). Plan disenrollment
is generally believed to be a broad
indicator of beneficiary dissatisfaction
with some aspect of plan services, such
as access to care, customer service, cost
of the plan, services, benefits provided,
or quality of care.
The information generated from the
disenrollment survey supports CMS’
ongoing efforts to assess plan
performance and provide oversight to
the functioning of Medicare Advantage
(Part C) and PDP (Part D) plans, which
provide health care services to millions
of Medicare beneficiaries (i.e., 28
million for Part C coverage and 49
million for Part D coverage).
Beneficiary experiences of care (as
measured in the MCAHPS survey) and
dissatisfaction (as measured in the
disenrollment survey) with plan
performance are both important sources
of information for plan monitoring and
oversight. The disenrollment survey
assesses different aspects of
dissatisfaction (i.e., reasons why
beneficiaries voluntarily left a plan),
which can identify problems with plan
operations; performance areas evaluated
include access to care, customer service,
cost, coverage, benefits provided, and
quality of care. Understanding how well
plans perform on these dimensions of
care and service helps CMS understand
whether beneficiaries are satisfied with
the care they are receiving from
contracted plans. When and if plans are
found to be performing poorly against
an array of performance measures,
including beneficiary disenrollment,
CMS may take corrective action. Form
Number: CMS–10316 (OMB control
number: 0938–1113); Frequency: Yearly;
Affected Public: Individuals and
Households; Number of Respondents:
32,750; Total Annual Responses:
32,750; Total Annual Hours: 7,055. (For
policy questions regarding this
collection contact Beth Simons at 415–
744–3780).
Dated: February 2, 2023.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2023–02580 Filed 2–6–23; 8:45 am]
BILLING CODE 4120–01–P
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Tribal Maternal, Infant, and
Early Childhood Home Visiting
Program Implementation Plan
Guidance for Development and
Implementation and Implementation
and Expansion Grantees
Office of Early Childhood
Development, Administration for
Children and Families, U.S. Department
of Health and Human Services.
ACTION: Request for public comments.
AGENCY:
The Administration for
Children and Families (ACF), Office of
Early Childhood Development (ECD) is
requesting Office of Management and
Budget (OMB) approval of Tribal
Maternal, Infant, and Early Childhood
Home Visiting (MIECHV) Program
Implementation Plan Guidance for
Tribal Home Visiting Development and
Implementation Grants (DIG) and Tribal
Home Visiting Implementation and
Expansion Grants (IEG).
DATES: Comments due within 60 days of
publication. In compliance with the
requirements of the Paperwork
Reduction Act (PRA) of 1995, ACF is
soliciting public comment on the
specific aspects of the information
collection described above.
ADDRESSES: You can obtain copies of the
proposed collection of information and
submit comments by emailing
infocollection@acf.hhs.gov. Identify all
requests by the title of the information
collection.
SUPPLEMENTARY INFORMATION:
Description: Section 511(e)(8)(A) of
title V of the Social Security Act
requires that grantees under the Tribal
MIECHV program, in the first year of
their grants, submit an implementation
plan on how they will meet the
requirements of the program. Section
511(h)(2)(A) further states that the
requirements for the MIECHV grants to
tribes, tribal organizations, and urban
Indian organizations are to be
consistent, to the greatest extent
practicable, with the requirements for
grantees under the MIECHV program for
states and jurisdictions.
The ACF Office of Early Childhood
Development, in collaboration with the
Health Resources and Services
Administration, Maternal and Child
Health Bureau awarded grants for the
Tribal MIECHV Program to support
cooperative agreements to conduct
community needs assessments; plan for
SUMMARY:
E:\FR\FM\07FEN1.SGM
07FEN1
Agencies
[Federal Register Volume 88, Number 25 (Tuesday, February 7, 2023)]
[Notices]
[Pages 7976-7978]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-02580]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifiers CMS-10704, CMS-10387, CMS-10846, CMS-R-246 and
CMS-10316]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (PRA), federal agencies are required to publish notice in
the Federal Register concerning each proposed collection of information
(including each proposed extension or reinstatement of an existing
collection of information) and to allow 60 days for public comment on
the proposed action. Interested persons are invited to send comments
regarding our burden estimates or any other aspect of this collection
of information, including the necessity and utility of the proposed
information collection for the proper performance of the agency's
functions, the accuracy of the estimated burden, ways to enhance the
quality, utility, and clarity of the information to be collected, and
the use of automated collection techniques or other forms of
information technology to minimize the information collection burden.
DATES: Comments must be received by April 10, 2023.
ADDRESSES: When commenting, please reference the document identifier or
OMB control number. To be assured consideration, comments and
recommendations must be submitted in any one of the following ways:
1. Electronically. You may send your comments electronically to
https://www.regulations.gov. Follow the instructions for ``Comment or
Submission'' or ``More Search Options'' to find the information
collection document(s) that are accepting comments.
2. By regular mail. You may mail written comments to the following
address: CMS, Office of Strategic Operations and Regulatory Affairs
Division of Regulations Development Attention: Document Identifier/OMB
Control Number: __, Room C4-26-05, 7500 Security Boulevard, Baltimore,
Maryland 21244-1850.
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, please access
the CMS PRA website by copying and pasting the following web address
into your web browser: https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.
FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786-4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the use and burden associated
with the following information collections. More detailed information
can be found in each collection's supporting statement and associated
materials (see ADDRESSES).
CMS-10704 Health Reimbursement Arrangements and Other Account-Based
Group Health Plans
CMS-10387 Minimum Data Set 3.0 Nursing Home and Swing Bed Prospective
Payment System (PPS) For the collection of data related to the Patient
Driven Payment Model and the Skilled Nursing Facility Quality Reporting
Program (QRP)
CMS-10846 Medicare Part D Manufacturer Discount Program Agreement
CMS-R-246 Medicare Advantage, Medicare Part D, and Medicare Fee-For-
Service Consumer Assessment of Healthcare Providers and Systems (CAHPS)
Survey
CMS-10316 Implementation of the Medicare Prescription Drug Plan (PDP)
and Medicare Advantage (MA) Plan Disenrollment Reasons Survey
Under the PRA (44 U.S.C. 3501-3520), federal agencies must obtain
approval from the Office of Management and Budget (OMB) for each
collection of information they conduct or sponsor. The term
``collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA
[[Page 7977]]
requires federal agencies to publish a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension or reinstatement of an existing collection of
information, before submitting the collection to OMB for approval. To
comply with this requirement, CMS is publishing this notice.
Information Collection
1. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Health
Reimbursement Arrangements and Other Account-Based Group Health Plans;
Use: On June 20, 2019, the Department of the Treasury, the Department
of Labor, and the Department of Health and Human Services
(collectively, the Departments) issued final regulations titled
``Health Reimbursement Arrangements and Other Account-Based Group
Health Plans'' (84 FR 28888) under section 2711 of the PHS Act and the
health nondiscrimination provisions of HIPAA, Public Law 104-191 (HIPAA
nondiscrimination provisions). The regulations expanded the use of
health reimbursement arrangements and other account-based group health
plans (collectively referred to as HRAs) and recognized certain HRAs as
limited excepted benefits (the excepted benefit HRA), for plan years
beginning on or after January 1, 2020. In general, the regulations
expanded the use of HRAs by eliminating the prohibition on integrating
HRAs with individual health insurance coverage, thereby permitting
employers to offer individual coverage HRAs to employees that can be
integrated with individual health insurance coverage or Medicare Parts
A and B, or Part C. Under the regulations, employees are permitted to
use amounts in an individual coverage HRA to pay expenses for medical
care (including premiums for individual health insurance coverage and
Medicare), subject to certain requirements. This information collection
includes provisions related to substantiation of individual health
insurance coverage (45 CFR 146.123(c)(5)), the notice requirement for
individual coverage HRAs (45 CFR 146.123(c)(6)), and notification of
termination of coverage (45 CFR 146.123(c)(1)(iii)). In the final rule
``Patient Protection and Affordable Care Act; HHS Notice of Benefit and
Payment Parameters for 2021; Notice Requirement for Non-federal
Governmental Plans'' (85 FR 29164), under 45 CFR
146.145(b)(3)(viii)(E), excepted benefit HRAs offered by non-Federal
governmental plan sponsors are required to provide a notice that
describes conditions pertaining to eligibility to receive benefits,
annual or lifetime caps or other limits on benefits under the excepted
benefit HRA, and a description or summary of the benefits. This notice
must be provided no later than 90 days after the employee becomes a
participant in the excepted benefit HRA and annually thereafter. Form
Number: CMS-10704 (OMB control number: 0938-1361); Frequency: Annually;
Affected Public: Private Sector, State Governments; Number of
Respondents: 11,574; Total Annual Responses: 1,037,674; Total Annual
Hours: 5,889. (For policy questions regarding this collection contact
Adam Pellillo at (667) 290-9621.)
2. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Minimum Data Set
3.0 Nursing Home and Swing Bed Prospective Payment System (PPS) For the
collection of data related to the Patient Driven Payment Model and the
Skilled Nursing Facility Quality Reporting Program (QRP); Use: We are
requesting to implement to the MDS 3.0 v1.18.11 beginning October 1,
2023 to October 1, 2026 in order to meet the requirements of policies
finalized in the Federal Fiscal Year (FY) 2020 Skilled Nursing Facility
(SNF) Prospective Payment System (PPS) final rule (84 FR 38728). The
compliance date for the finalized policies (10/01/2020) was delayed due
to the COVID-19 public health emergency (PHE). While there has been no
change in assessment-level burden since the approval of the MDS 3.0
v1.17.2, there has been a change in total burden since 2019 when the
package was originally approved due to a decrease in the number of MDS
assessments completed and a change in the hourly rate for clinicians
completing the assessment.
We use the MDS 3.0 PPS Item Set to collect the data used to
reimburse skilled nursing facilities for SNF-level care furnished to
Medicare beneficiaries and to collect information for quality measures
and standardized patient assessment data under the SNF QRP. There have
been some revisions to the assessment tool since the approval of MDS
3.0 v1.17.2. Form Number: CMS-10387 (OMB control number: 0938-1140);
Frequency: Yearly; Affected Public: Private Sector: Business or other
for-profit and not-for-profit institutions; Number of Respondents:
15,472; Total Annual Responses: 3,371,993; Total Annual Hours:
2,866,194. (For policy questions regarding this collection contact
Heidi Magladry at 410-786-6034).
3. Type of Information Collection Request: New Collection (Request
for a new OMB control number); Title of Information Collection:
Medicare Part D Manufacturer Discount Program Agreement; Use: Congress
enacted the Inflation Reduction Act of 2022, Public Law 117-169 (IRA).
Section 11201 of the IRA eliminates the coverage gap phase of the Part
D benefit. It also sunsets the coverage gap discount program (CGDP)
after December 31, 2024, and amends the Social Security Act (the Act)
to add section 1860D-14C, requiring the Secretary to establish a new
Medicare Part D manufacturer discount program (MDP) beginning January
1, 2025. Under the MDP, participating manufacturers are required to
provide discounts on their ``applicable drugs'' (brand drugs,
biologics, and biosimilars) both in the initial coverage phase and in
the catastrophic coverage phase of the Part D benefit.
Information in this collection is needed to set up agreements
between manufacturers and CMS. Under section 1860D-14C(a) of the Act,
such agreements are required for manufacturers in order to participate
in the MDP and, under section 1860D43(a) of the Act, for their
applicable drugs to be covered under Part D beginning in 2025. The
information collected from manufacturers in the Health Plan Management
System (HPMS) (Appendix A) is needed to create and execute MDP
agreements and to determine which manufacturers qualify as a specified
manufacturer or specified small manufacturer for phased-in discounts
under section 1860D-14C(g)(4) of the Act. Banking information collected
by the TPA from manufacturers and plan sponsors (Appendix B) is needed
to prepare invoices and process financial transactions (deposits and
payments) through the ACH. Form Number: CMS-10846 (OMB control number:
0938-New); Frequency: Once; Affected Public: Private Sector: Business
or other for-profit and not-for-profit institutions; Number of
Respondents: 659; Total Annual Responses: 659; Total Annual Hours:
4,613. (For policy questions regarding this collection contact Beckie
Peyton at 410-786-1572).
4. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Medicare
Advantage, Medicare Part D, and Medicare Fee-For-Service Consumer
Assessment of Healthcare Providers and Systems (CAHPS) Survey; Use: CMS
is required to collect and report
[[Page 7978]]
information on the quality of health care services and prescription
drug coverage available to persons enrolled in a Medicare health or
prescription drug plan under provisions in the Medicare Prescription
Drug, Improvement, and Modernization Act of 2003 (MMA). Specifically,
the MMA under Sec. 1860D-4 (Information to Facilitate Enrollment)
requires CMS to conduct consumer satisfaction surveys regarding
Medicare prescription drug plans and Medicare Advantage plans and
report this information to Medicare beneficiaries prior to the Medicare
annual enrollment period. The Medicare CAHPS survey meets the
requirement of collecting and publicly reporting consumer satisfaction
information. The Balanced Budget Act of 1997 also requires the
collection of information about fee-for-service plans.
The primary purpose of the Medicare CAHPS surveys is to provide
information to Medicare beneficiaries to help them make more informed
choices among health and prescription drug plans available to them.
Survey results are reported by CMS in the Medicare & You Handbook
published each fall and on the Medicare Plan Finder website.
Beneficiaries can compare CAHPS scores for each health and drug plan as
well as compare MA and FFS scores when making enrollment decisions. The
Medicare CAHPS also provides data to help CMS and others monitor the
quality and performance of Medicare health and prescription drug plans
and identify areas to improve the quality of care and services provided
to enrollees of these plans. CAHPS data are included in the Medicare
Part C & D Star Ratings and used to calculate MA Quality Bonus
Payments. Form Number: CMS-R-246 (OMB control number: 0938- 0732);
Frequency: Yearly; Affected Public: Individuals and Households; Number
of Respondents: 794,500; Total Annual Responses: 794,500; Total Annual
Hours: 192,265. (For policy questions regarding this collection contact
Lauren Fuentes at 410-786-2290).
5. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Implementation of
the Medicare Prescription Drug Plan (PDP) and Medicare Advantage (MA)
Plan Disenrollment Reasons Survey; Use: The Balanced Budget Act of 1997
required that the CMS publicly report two years of disenrollment rates
on all Medicare + Choice (M+C) organizations. Disenrollment rates are a
useful measure of beneficiary dissatisfaction with a plan; this
information is even more useful when reasons for disenrollment are
provided to consumers, insurers, and other stakeholders. Advocacy
organizations agree that CMS needs to report disenrollment reasons so
that disenrollment rates can be interpreted correctly.
Specifically, the MMA under Sec. 1860D-4 (Information to Facilitate
Enrollment) requires CMS to conduct consumer satisfaction surveys
regarding the PDP and MA contracts pursuant to section 1860D-4(d). Plan
disenrollment is generally believed to be a broad indicator of
beneficiary dissatisfaction with some aspect of plan services, such as
access to care, customer service, cost of the plan, services, benefits
provided, or quality of care.
The information generated from the disenrollment survey supports
CMS' ongoing efforts to assess plan performance and provide oversight
to the functioning of Medicare Advantage (Part C) and PDP (Part D)
plans, which provide health care services to millions of Medicare
beneficiaries (i.e., 28 million for Part C coverage and 49 million for
Part D coverage).
Beneficiary experiences of care (as measured in the MCAHPS survey)
and dissatisfaction (as measured in the disenrollment survey) with plan
performance are both important sources of information for plan
monitoring and oversight. The disenrollment survey assesses different
aspects of dissatisfaction (i.e., reasons why beneficiaries voluntarily
left a plan), which can identify problems with plan operations;
performance areas evaluated include access to care, customer service,
cost, coverage, benefits provided, and quality of care. Understanding
how well plans perform on these dimensions of care and service helps
CMS understand whether beneficiaries are satisfied with the care they
are receiving from contracted plans. When and if plans are found to be
performing poorly against an array of performance measures, including
beneficiary disenrollment, CMS may take corrective action. Form Number:
CMS-10316 (OMB control number: 0938-1113); Frequency: Yearly; Affected
Public: Individuals and Households; Number of Respondents: 32,750;
Total Annual Responses: 32,750; Total Annual Hours: 7,055. (For policy
questions regarding this collection contact Beth Simons at 415-744-
3780).
Dated: February 2, 2023.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2023-02580 Filed 2-6-23; 8:45 am]
BILLING CODE 4120-01-P